Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.USPTO Issues Patent To Salix
The US Patent and Trademark Office (USPTO) has issued US Patent No 7,612,199 (the ‘199 patent) entitled “Polymorphic Forms Alpha, Beta, and Gamma of Rifaximin” to Salix Pharmaceuticals
The US Patent and Trademark Office (USPTO) has issued US Patent No 7,612,199 (the ‘199 patent) entitled “Polymorphic Forms Alpha, Beta, and Gamma of Rifaximin” to Salix Pharmaceuticals
Symphogen has opened its US headquarters in Princeton, New Jersey. Adriann Sax, Symphogen’s recently appointed chief business officer, will head the company’s US business which will operate as
Lonza has enhanced its protein design technology offering for biopharmaceutical development by acquiring Algonomics. Effective November 2, 2009, Lonza has acquired all shares of Algonomics including the proprietary
Biomarkers are small molecules that indicate the presence of a particular physiological condition, typically a disease. The new method, if successful, could prove useful not just for identifying
AllTranz is awarded a $4m research grant from the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH), to advance the company’s
Medpace has entered into a purchase agreement to acquire Pharma Brains , an oncology focused CRO based in Basel, Switzerland. Pharma Brains is expected to provide Medpace with
InteRNA Technologies and the Dana-Farber Cancer Institute have entered into a research agreement to develop microRNA (miRNA)-based therapeutics for cancer. Under the collaboration with William Hahn, associate professor
Solasia Pharma (Solasia) has completed phase I clinical trial for SP-01 (extended release transdermal granisetron patch, brand name: Sancuso ) in Japanese volunteers. Sancuso is the first and
Aflex Hose has unveiled Corroline, a flexible hose developed to stand up to the toughest chemical and process applications. Corroline is built around a patented PTFE (polytetrafluoroethylene) hose
According to results of an intent-to-treat (ITT) analysis announced by Vertex Pharmaceuticals, more than 80% of hepatitis C patients in each arm of the phase 2 Study C208